O	0	11	Development	Development	NN	B-NP
O	12	15	and	and	CC	I-NP
O	16	26	validation	validation	NN	I-NP
O	27	29	of	of	IN	B-PP
O	30	32	an	an	DT	B-NP
O	33	41	approach	approach	NN	I-NP
O	42	44	to	to	TO	B-VP
O	45	52	produce	produce	VB	I-VP
O	53	58	large	large	JJ	B-NP
O	58	59	-	-	HYPH	I-NP
O	59	64	scale	scale	NN	I-NP
O	65	75	quantities	quantity	NNS	I-NP
O	76	78	of	of	IN	B-PP
O	79	82	CpG	CpG	NN	B-NP
O	82	83	-	-	HYPH	B-NP
O	83	93	methylated	methylate	VBN	I-NP
B-Cellular_component	94	101	plasmid	plasmid	NN	I-NP
O	102	105	DNA	DNA	NN	I-NP
O	105	106	.	.	.	O

O	107	110	The	The	DT	B-NP
O	111	122	prokaryotic	prokaryotic	JJ	I-NP
O	123	126	CpG	CpG	NN	I-NP
O	126	127	-	-	HYPH	B-NP
O	127	135	specific	specific	JJ	I-NP
O	136	139	DNA	DNA	NN	I-NP
O	140	149	methylase	methylase	NN	I-NP
O	150	154	from	from	IN	B-PP
O	155	166	Spiroplasma	Spiroplasma	NN	B-NP
O	166	167	,	,	,	O
O	168	172	SssI	SssI	NN	B-NP
O	173	182	methylase	methylase	NN	I-NP
O	182	183	,	,	,	O
O	184	187	has	have	VBZ	B-VP
O	188	192	been	be	VBN	I-VP
O	193	204	extensively	extensively	RB	I-VP
O	205	209	used	use	VBN	I-VP
O	210	212	to	to	TO	B-VP
O	213	222	methylate	methylate	VB	I-VP
B-Cellular_component	223	230	plasmid	plasmid	NN	B-NP
O	231	234	DNA	DNA	NN	I-NP
O	235	237	in	in	FW	B-ADVP
O	238	243	vitro	vitro	FW	I-ADVP
O	244	246	to	to	TO	B-VP
O	247	258	investigate	investigate	VB	I-VP
O	259	262	the	the	DT	B-NP
O	263	270	effects	effect	NNS	I-NP
O	271	273	of	of	IN	B-PP
O	274	285	methylation	methylation	NN	B-NP
O	286	288	in	in	IN	B-PP
O	289	299	vertebrate	vertebrate	NN	B-NP
O	300	307	systems	system	NNS	I-NP
O	307	308	.	.	.	O

O	309	318	Currently	Currently	RB	B-NP
O	319	328	available	available	JJ	I-NP
O	329	336	methods	method	NNS	I-NP
O	337	339	to	to	TO	B-VP
O	340	347	produce	produce	VB	I-VP
O	348	351	CpG	CpG	NN	B-NP
O	351	352	-	-	HYPH	O
O	352	362	methylated	methylate	VBN	B-NP
B-Cellular_component	363	370	plasmid	plasmid	NN	I-NP
O	371	374	DNA	DNA	NN	I-NP
O	375	379	have	have	VBP	B-VP
O	380	387	certain	certain	JJ	B-NP
O	388	399	limitations	limitation	NNS	I-NP
O	400	403	and	and	CC	O
O	404	410	cannot	cannot	MD	B-VP
O	411	419	generate	generate	VB	I-VP
O	420	425	large	large	JJ	B-NP
O	426	436	quantities	quantity	NNS	I-NP
O	437	439	of	of	IN	B-PP
O	440	450	methylated	methylate	VBN	B-NP
O	451	454	DNA	DNA	NN	I-NP
O	455	462	without	without	IN	B-PP
O	463	467	cost	cost	NN	B-NP
O	468	470	or	or	CC	I-NP
O	471	479	problems	problem	NNS	I-NP
O	480	482	of	of	IN	B-PP
O	483	489	purity	purity	NN	B-NP
O	489	490	.	.	.	O

O	491	495	Here	Here	RB	B-ADVP
O	496	498	we	we	PRP	B-NP
O	499	507	describe	describe	VBP	B-VP
O	508	510	an	an	DT	B-NP
O	511	519	approach	approach	NN	I-NP
O	520	522	in	in	IN	B-PP
O	523	528	which	which	WDT	B-NP
O	529	532	the	the	DT	B-NP
O	533	537	SssI	SssI	NN	I-NP
O	538	547	methylase	methylase	NN	I-NP
O	548	552	gene	gene	NN	I-NP
O	553	556	has	have	VBZ	B-VP
O	557	561	been	be	VBN	I-VP
O	562	572	introduced	introduce	VBN	I-VP
O	573	577	into	into	IN	B-PP
O	578	581	the	the	DT	B-NP
O	582	593	Escherichia	Escherichia	FW	I-NP
O	594	598	coli	coli	FW	I-NP
O	599	608	bacterial	bacterial	JJ	I-NP
O	609	615	genome	genome	NN	I-NP
O	616	621	under	under	IN	B-PP
O	622	625	the	the	DT	B-NP
O	626	633	control	control	NN	I-NP
O	634	636	of	of	IN	B-PP
O	637	639	an	an	DT	B-NP
O	640	649	inducible	inducible	JJ	I-NP
O	650	658	promoter	promoter	NN	I-NP
O	658	659	.	.	.	O

B-Cellular_component	660	667	Plasmid	Plasmid	NN	B-NP
O	668	671	DNA	DNA	NN	I-NP
O	672	682	propagated	propagate	VBN	B-VP
O	683	685	in	in	IN	B-PP
O	686	690	this	this	DT	B-NP
O	691	700	bacterium	bacterium	NN	I-NP
O	701	706	under	under	IN	B-PP
O	707	717	conditions	condition	NNS	B-NP
O	718	723	which	which	WDT	B-NP
O	724	730	induce	induce	VBP	B-VP
O	731	734	the	the	DT	B-NP
O	735	744	methylase	methylase	NN	I-NP
O	745	749	gene	gene	NN	I-NP
O	750	756	result	result	VBP	B-VP
O	757	759	in	in	IN	B-PP
O	760	771	significant	significant	JJ	B-NP
O	772	773	(	(	(	O
O	773	774	>	>	JJR	B-NP
O	774	776	90	90	CD	I-NP
O	776	777	%	%	NN	I-NP
O	777	778	)	)	)	O
O	779	782	CpG	CpG	NN	B-NP
O	783	794	methylation	methylation	NN	I-NP
O	794	795	.	.	.	O

O	796	806	Methylated	Methylate	VBN	B-NP
O	807	810	DNA	DNA	NN	I-NP
O	811	819	produced	produce	VBN	B-VP
O	820	822	by	by	IN	B-PP
O	823	827	this	this	DT	B-NP
O	828	836	approach	approach	NN	I-NP
O	837	844	behaves	behave	VBZ	B-VP
O	845	854	similarly	similarly	RB	B-ADVP
O	855	857	to	to	TO	B-PP
O	858	868	methylated	methylate	VBN	B-NP
O	869	872	DNA	DNA	NN	I-NP
O	873	881	produced	produce	VBN	B-VP
O	882	884	in	in	FW	B-ADVP
O	885	890	vitro	vitro	FW	I-ADVP
O	891	896	using	use	VBG	B-VP
O	897	900	the	the	DT	B-NP
O	901	909	purified	purify	VBN	I-NP
O	910	919	methylase	methylase	NN	I-NP
O	919	920	.	.	.	O

O	921	924	The	The	DT	B-NP
O	925	933	approach	approach	NN	I-NP
O	934	936	is	be	VBZ	B-VP
O	937	945	scalable	scalable	JJ	B-ADJP
O	946	954	allowing	allow	VBG	B-VP
O	955	958	for	for	IN	B-PP
O	959	962	the	the	DT	B-NP
O	963	973	production	production	NN	I-NP
O	974	976	of	of	IN	B-PP
O	977	986	milligram	milligram	NN	B-NP
O	987	997	quantities	quantity	NNS	I-NP
O	998	1000	of	of	IN	B-PP
O	1001	1011	methylated	methylate	VBN	B-NP
B-Cellular_component	1012	1019	plasmid	plasmid	NN	I-NP
O	1020	1023	DNA	DNA	NN	I-NP
O	1023	1024	.	.	.	O

